Strategy question

A healthcare customer executive is pushing for aggressive automation but is worried about patient safety and PHI exposure. How would you recommend which workflows to automate first, which to keep human-led, and how would you frame the tradeoff between higher containment and maintaining trust?

Practice this question out loud. An AI interviewer asks it, follows up like a real interviewer would, and scores your answer. Type or speak.

What this question tests

Tests judgment on automation scope in a regulated healthcare setting, balancing executive pressure for speed against patient safety and PHI risk.

Separate workflows by reversibility and PHI sensitivity, automating low risk, easily reversible ones like appointment reminders first.
Keep clinically sensitive workflows, like symptom triage or medication guidance, human led or human in the loop regardless of executive pressure.
Frame the tradeoff for the executive concretely: higher containment now on sensitive workflows risks a safety incident that costs far more in trust and regulatory exposure later.
Propose a phased plan where early wins on low risk workflows build the case and the infrastructure for expanding automation carefully over time.
Involve compliance and clinical safety stakeholders directly in defining which workflows are automatable, rather than making the call unilaterally with the executive.
Set measurable trust indicators, like patient complaint rate and clinician override rate, as the gate for expanding automation to more sensitive workflows.

Reframes the executive's speed pressure around long term trust risk rather than simply pushing back, which is more persuasive and honest.
Uses reversibility and PHI sensitivity as the concrete criteria for automation scope, not a vague sense of what feels safe.
Proposes a phased plan that gives the executive visible early wins while protecting sensitive workflows, rather than an all or nothing stance.

Automating clinically sensitive workflows to satisfy executive pressure without adequate safety review.
Refusing all automation broadly instead of finding low risk workflows that can move fast and build trust.

What specific evidence would you need before expanding automation to a more sensitive workflow?
How would you handle it if the executive insists on full automation despite the compliance team's objection?